Showing results (581-590 of 804) with videos related to

Sort By:
Pageof 81
The Journal of Experimental Medicine|December 22, 1998
Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growthS E Pike, L Yao, K D Jones, et al.
Endocrine-Related Cancer|March 6, 2012
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathwayHongbing Chen, Yin Sun, Chengyu Wu, et al.
Cancer|January 20, 2021
Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancersChristopher M K L Yao, Shuangshuang Fu, Samantha Tam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2011
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal originSean R Williamson, Shaobo Zhang, Jorge L Yao, et al.
Molecular Endocrinology (Baltimore, Md.)|November 4, 2006
Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growthZhiming Yang, Yu-Jia Chang, Hiroshi Miyamoto, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 17, 2023
[Association between clinical phenotypes of hypertrophic cardiomyopathy and Ca2+ gene variation gene variation]J Zhao, B Wang, L Yao, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 18, 2019
[Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery]Q Tang, R C Lin, L Yao, et al.
Human Pathology|May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
Neuropeptides|February 1, 1985
Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patientsA Z Zhang, G Z Zhou, G F Xi, et al.
The Journal of International Medical Research|February 14, 2009
Quantitative assay for Janus kinase 2 (JAK2) mutation in Chinese patients with chronic myeloproliferative disordersY-M Shen, H-Y Chao, R Zhang, et al.
Pageof 81